Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 2008, p. 1881-1884, Vol. 46, No. 5
0095-1137/08/$08.00+0 doi:10.1128/JCM.01875-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Division of Comparative Medicine, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Bldg 16-825, Cambridge, Massachusetts 02139
Received 20 September 2007/ Returned for modification 20 November 2007/ Accepted 27 February 2008
|
|
|---|
|
|
|---|
Clinical history. Over an 11-month period, 28 Swiss Webster mice were submitted for necropsy with a history of abscesses or ulcerative skin lesions over the muzzle, limbs, and/or inguinal region. A standard workup for murine viruses and parasites was negative in all animals. This incidence of serious skin disease far exceeded background levels in our mouse facility, prompting the search for an underlying cause.
Gross pathology. Affected mice demonstrated cutaneous erythema or ulceration and epidermal thickening and often had disfiguring abscesses with tan-to-yellow-green purulent material on cut surfaces, most often on the muzzle or limbs (Fig. 1A). Others presented with a predominantly ulcerative form of dermatitis concentrated in the inguinal region. Generalized alopecia suggestive of the athymic nude mouse phenotype was not apparent (8).
![]() View larger version (148K): [in a new window] |
FIG. 1. Morphology and immunohistochemical characterization of cutaneous botryomycosis and lymphoid organ immaturity and B-cell deficiency in affected Swiss Webster mice. (A) Gross appearance of cutaneous muzzle abscess (left) and inguinal ulcerative dermatitis (right; arrows). (B) High-power magnification of coccoid bacterial colonies (arrow) bounded by a rim of hyaline eosinophilic material (Splendore-Hoeppli phenomenon; arrowheads) and mixed inflammatory cells. (C) Histology (left column) and immunohistochemistry (right four columns) of cutaneous botryoid granuloma and of lymphoid organs including thymus, mesenteric lymph node (MLN), and spleen. The botryoid granuloma is characterized by a central core of coccoid bacteria and CD3+ T cells bounded and infiltrated by F4/80+ macrophages and MPO+ neutrophils (bacteria also labeled with the MPO antibody). Note the paucity of CD45R/B220 (B220+) B cells. The thymus is packed with T cells without apparent follicular organization or corticomedullary junction distinction; there are pockets of individual B cells. MLN and spleen contain abundant T cells with no discernible follicular organization, exhibit severe depletion of B cells, and have markedly increased numbers of monocytes/macrophages and granulocytes, consistent with compensatory extramedullary myelopoiesis. Panel B and the left column of panel C exhibit hematoxylin and eosin (H&E) staining; the right four columns of panel C show diaminobenzidine immunohistochemistry with hematoxylin counterstain. Bars = 40 µm (B), 160 µm (C, all rows except thymus row), and 400 µm (C, thymus row).
|
Immunohistochemistry. Cutaneous granulomas, thymus, lymph node, and spleen were labeled with antibodies to identify T cells (CD3), B cells (CD45R/B220), macrophages (F4/80), and neutrophils (myeloperoxidase [MPO]). Skin granulomas contained a central core of CD3+ T cells immediately surrounding granules of basophilic cocci bounded by Splendore-Hoeppli material (botryomycosis) (Fig. 1C). T cells in turn were bounded and infiltrated by F4/80+ macrophages and MPO+ neutrophils. B220+ B cells were extremely rare. The thymus was filled with T cells without any discernible follicular organization or corticomedullary junction (Fig. 1C). There were isolated pockets of B cells but no macrophages or granulocytes. Lymph nodes also lacked corticofollicular organization and exhibited pronounced extramedullary myelopoiesis characterized by abundant immature monocyte/macrophages and polymorphonuclear cells. The same lack of lymphoid organization with increased myelopoiesis was evident in the spleen, along with erythropoiesis.
Complete blood count. Peripheral lymphocyte counts of B-cell-deficient mice were compared with two different control groups descended from the same set of breeding pairs: (i) mice with a history of skin lesions and normal lymphoid organ histomorphology; and (ii) sentinel mice submitted for scheduled necropsy with no abnormalities of the skin or lymphoid organs. The mean circulating lymphocyte count of B-cell-deficient mice was (3.1 ± 0.46) x 103/µl. This value was significantly lower by the unpaired Student t test (P < 0.05) (Prism software; GraphPad, San Diego, CA) than that of mice with skin lesions and normal lymphoid histology (5.76 x 103/µl ± 0.41 x 103/µl) or control mice with no abnormalities (6.16 x 103/µl ± 0.42 x 103/µl) (Fig. 2). Although we were unable to determine the identity of circulating lymphocytes, based on immunohistochemistry we attributed the decreased circulating lymphocyte count in affected animals to a severe depletion of B cells.
![]() View larger version (20K): [in a new window] |
FIG. 2. Circulating gammaglobulin levels and lymphocyte counts in B-cell-deficient versus immunocompetent mice. All mice with immunohistochemical confirmation of B-cell deficiency had undetectable serum IgG levels (first column) versus variable but detectable IgG levels for all mice with normal lymphoid organ histology (second column) (P < 0.001). B-cell-deficient agammaglobulinemic mice also had significantly lower circulating lymphocyte counts (third column) than did immunocompetent mice (fourth column) (P < 0.01). (Circulating lymphocytes in agammaglobulinemic mice were probably T cells, although we were unable to confirm this.) Horizontal lines indicate means.
|
Serum gammaglobulin. Total serum gammaglobulin levels were measured using the mouse serum immunoglobulin G (IgG) enzyme-linked immunosorbent assay kit (Alpha Diagnostic International, San Antonio, TX). All B-cell-deficient mice had undetectable serum IgG (<2.4 mg/ml) and were defined as agammaglobulinemic. In contrast, mean serum IgG in lymphocompetent control mice with skin lesions was 6.76 mg/ml, and the level for healthy controls was 5.37 mg/ml (both P values were <0.001 versus B-cell-deficient mice; the Student t test) (Fig. 2). Moreover, there were significant associations between cutaneous botryomycosis, histological B-cell deficiency, and agammaglobulinemia (all P values were <0.001; Fisher's exact test). In contrast, there was no association between the recovery of S. aureus from airways or skin and any histological or blood parameter measured (data not shown).
Sentinel mouse immunocompetence is critical to the success of surveillance programs that rely on seroconversion for the detection of murine pathogens. Whereas sporadic cases of S. aureus botryomycosis are not unusual in our colony and others, the occurrence of so many cases over 11 months significantly exceeded our historical incidence, prompting additional investigation. Strong associations were found between botryomycosis, histological B-cell deficiency, circulating lymphopenia, and agammaglobulinemia. The identification by immunohistochemistry of T cells but not B cells in lymphoid organs was consistent with the decreased circulating lymphocyte counts and agammaglobulinemia. A review of clinical record searches ascertained that the lineage of all agammaglobulinemic mice could be traced to eight Swiss Webster breeding pairs purchased from a single vendor. We concluded that the disease was heritable, although we did not pursue a specific genetic defect. Because there was no sex predilection, it was unlikely to be analogous to human X-linked agammaglobulinemia due to a defect in Bruton's tyrosine kinase gene. However, there are many forms of human agammaglobulinemia with no sex disparity, resulting from mutations to a wide variety of chromosomes.
The location and histological character of botryomycosis in affected mice was consistent with the introduction of S. aureus through bite wounds (limbs) and barbering (muzzle). Abe et al. described the experimental inoculation of mouse skin with S. aureus in which hair follicles were invaded within 12 h of exposure, while Akiyama et al. described clusters of S. aureus colonies and formation of a biofilm in the dermal and subcutaneous skin of mice treated with the immunosuppressive drug cyclophosphamide prior to bacterial inoculation (1, 3). S. aureus is an organism often found in the skin flora of healthy humans. Nagase et al. concluded that S. aureus was not a typical member of laboratory mouse skin flora (9), although the organism was readily cultured from both healthy and ill animals in our facility. A report of an outbreak of S. aureus-related facial and mandibular abscesses within a colony of outbred BVSV mice was attributed to a human carrier (7). S. aureus-related botryoid abscesses have been reported with high frequency in athymic nude mice (12). Direct human contact and contaminated medical devices are important sources of transmission of this and other opportunistic microorganisms in hospital settings (15). It is interesting that the botryoid lesions in affected mice exhibited the classical Splendore-Hoeppli phenomenon, characterized by a hyaline rim of smooth and club-shaped eosinophilic material surrounding bacterial colonies. Splendore-Hoeppli material purportedly is comprised of a mixture of degenerate cell debris and host Igs. However, affected mice in our study had no detectable serum IgG, suggesting that Igs may be dispensable to this process.
Murine models of combined B- and T-cell immunodeficiency, including SCID-, Rag-1-, and Rag-2-deficient mice, are well-known and widely used in research. Conversely, mouse models of pure B-cell deficiency are less pervasive. Murine models of spontaneous B-cell deficiency and hypogammaglobulinemia include A/WnSynJ, XID, and µMt–/– mice, while examples of mutations resulting in abnormal or failed organogenesis of Peyer's patches and myeloid dendritic cells include defects in nuclear factors such as NF-
B1, NF-
B2, and Bcl-3 (10). Spontaneous hypogammaglobulinemia and B-cell deficiency in A/WySnJ mice and B-cell-activating factor-deficient (BAFF–/–) mice are the result of receptor mutations in the tumor necrosis factor receptor superfamily and cause maturational defects and premature apoptosis of primary and transitional B cells (4, 11). Unlike the spontaneous disease with no sex predilection we have described here, the XID mouse model provides a model of human X-linked agammaglobulinemia due to a defect in Bruton's tyrosine kinase gene. This spontaneous mutation affects the signal transduction of B cells and results in maturational arrest, profoundly decreased peripheral B cells, hypogammaglobulinemia, and hypoplastic lymphoid tissue (13). The role of B cells also extends to immunomodulation, as Akhiani et al. (2) demonstrated with Helicobacter pylori-infected wild-type and µMt–/– mice. Mice with the mutation have defects in the mu heavy chain, resulting in a maturational block of pre-B lymphocytes. The study examined H. pylori gastric colonization and the subsequent onset of gastritis and showed that while initial colonization density was lower in µMt–/– mice, more-severe gastric inflammation with eosinophilia and CD4+ T cells developed in the absence of B cells and antibodies (2).
In summary, we report the spontaneous emergence of agammaglobulinemia with B-cell deficiency and cutaneous botryomycosis in a cohort of Swiss Webster mice. Although an outbreeding regimen was followed at our facility, all affected animals were traced to eight original breeding pairs purchased from a single vendor, suggesting a heritable defect. Therefore, the immunocompetence of outbred mice maintained as sentinels cannot be presumed. Depopulation of the affected group of animals combined with the introduction of new sentinels from another vendor has resulted in a return of skin disease incidence in our facility to historic background levels. As a result of this experience, we have incorporated periodic testing of total serum IgG as an adjunct to histology and complete blood count in order to validate the immunocompetence of sentinel mice in our laboratory animal surveillance program.
This work was supported by National Institutes of Health grant T32RRO7036 (J.G.F.).
Published ahead of print on 5 March 2008. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»